Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the primary causes of chronic liver disease and is closely linked to insulin resistance, type 2 diabetes mellitus (T2DM), and dyslipidemia. However, no effective drug therapies have been approved to treat this disease. The present resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Wenlan, Zhang, Chen, Gu, Xuefang, Li, Xiaohong, Zhu, Huiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218939/
https://www.ncbi.nlm.nih.gov/pubmed/34168429
http://dx.doi.org/10.2147/DDDT.S307257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218939/
https://www.ncbi.nlm.nih.gov/pubmed/34168429
http://dx.doi.org/10.2147/DDDT.S307257

Ejemplares similares